Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT05340426Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT01795950Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
NCT06878560Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
NCT03367312Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
NCT03804944Converting HR+ Breast Cancer Into an Individualized Vaccine
NCT00147199Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
NCT01273922Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
NCT03180957Repurposing Anti-TNF for Treating Dupuytren's Disease
NCT04084678Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT01557660Inhaled Treprostinil for PAH: Open-label Extension
NCT02279745Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
NCT02276872Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
NCT06450041NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT01494896Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
NCT04090866Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
NCT02370095Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT06335407Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
NCT06425796Adiposity and Iron Requirements in Pregnancy
NCT04411680Study of Sargramostim in Patients With COVID-19
NCT04827056Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
NCT03047369The Myelin Disorders Biorepository Project
NCT07612488A Study of CS231295 in Patients With Advanced Solid Tumors
NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT00373360Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
NCT01996254Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT01447407Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
NCT04712266A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
NCT00969722A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT00262106Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT03950739Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
NCT00963027Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT04707664Sargramostim Use in COVID-19 to Recover Patient Health
NCT03043651Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
NCT00325403FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT01028651A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT03626688A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT06374459Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
NCT01884038Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients
NCT01104870A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
NCT02893995Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT01302444Treprostinil Combined With Tadalafil for Pulmonary Hypertension
NCT03888365Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH